Literature DB >> 7511318

Psychopathology and family functioning in mothers with epilepsy.

C Thiels1, H C Steinhausen.   

Abstract

In a prospective comparative study of children born to mothers with epilepsy and to healthy controls, maternal psychopathology, family functioning and the effects of maternal psychopathology and family functioning on child mental status were investigated. The instruments used were the Present State Examination (PSE), the Past History Schedule (PHS), a psychiatric interview for preschool children and a structured interview about family functioning. Interviewers were blind to the clinical status of the mother. The group of mothers with epilepsy differed from the control group only regarding a higher prevalence of minor psychopathology and in 1 of 4 areas of family functioning. There was no difference between mothers with epilepsy and the control group regarding major psychopathology, and almost no differences regarding family functioning. The effect of maternal psychopathology on child mental status was mediated by disturbed family functioning only in the epilepsy group.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7511318     DOI: 10.1111/j.1600-0447.1994.tb01481.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  3 in total

1.  Being parents with epilepsy: thoughts on its consequences and difficulties affecting their children.

Authors:  Helena Gauffin; Gullvi Flensner; Anne-Marie Landtblom
Journal:  Neuropsychiatr Dis Treat       Date:  2015-05-27       Impact factor: 2.570

Review 2.  Young People's Response to Parental Neurological Disorder: A Structured Review.

Authors:  Lilian Hartman; Crispin Jenkinson; David Morley
Journal:  Adolesc Health Med Ther       Date:  2020-03-26

3.  Epilepsy and violence: case series concerning physical trauma in children of persons with epilepsy.

Authors:  Helena Gauffin; Anne-Marie Landtblom
Journal:  Neuropsychiatr Dis Treat       Date:  2014-11-14       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.